Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological Malignancies

Clinical trial NCT00150462 · COMPLETED

Trial details

NCT number: NCT00150462
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Waldenstrom's Macroglobulinemia Non-Hodgkin's Lymphoma Hodgkin's Disease Multiple Myeloma

Start date: 2005-09-01
Primary completion: 2009-10-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.